CAVALLARO, FRANCESCA
CAVALLARO, FRANCESCA
Universita' degli Studi di MILANO
Viral respiratory infections in patients with hematological diseases over 10 years: epidemiology and impact on disease severity
2025 P. Bono, A. Parisi, E. Tagliaferri, R. Ungaro, G. Saporiti, F. Cavallaro, G. Bozzi, M.C. Goldaniga, G. Galli, N. Hejazifar, S. Allaria, C. Biassoni, G. Giacomel, A. Valzano, M. Sciumè, N. Fracchiolla, A. Bandera, F. Passamonti, A. Callegaro, C. Alteri
Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma
2024 G.A. Croci, L. Appio, C. Cecchetti, S. Tabano, S. Alberti-Violetti, E. Berti, D. Rahal, F. Cavallaro, F. Onida, D. Tomasini, E. Todisco
Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience
2023 G. Cassanello, F. Serpenti, F. Bagnoli, G. Saporiti, M. Goldaniga, F. Cavallaro, K. Barbullushi, V. Bellani, G. Galassi, F. Onida
Antibody based therapeutics for autoimmune hemolytic anemia
2023 F. Cavallaro, W. Barcellini, B. Fattizzo
Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse
2022 F. Serpenti, M. Sciumè, G. Galassi, G. Saporiti, F. Grifoni, N. Rampi, F. Cavallaro, K. Barbullushi, E. Tagliaferri, M. Goldaniga, L. Baldini, N.S. Fracchiolla, F. Onida
Breakthrough haemolysis in paroxysmal nocturnal haemoglobinuria after COVID-19 infection and COVID vaccination: what is worse?
2022 F. Cavallaro, M.C. Pasquini, J.A. Giannotta, F. Cattina, W. Barcellini, B. Fattizzo
Pyruvate Kinase Deficiency: Current Challenges and Future Prospects
2022 B. Fattizzo, F. Cavallaro, A.P.M.L. Marcello, C. Vercellati, W. Barcellini
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
2022 M. Manzoni, A. Bosi, S. Fabris, M. Lionetti, S. Salerio, A.C. Migliorini, F. Cavallaro, K. Barbullushi, N. Rampi, V. Montefusco, M.G. Alessio, A. Neri, L. Baldini, M. Sciumè, E. Tagliaferri, N. Fracchiolla, N. Bolli
Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective
2022 B. Fattizzo, F. Cavallaro, E.N. Oliva, W. Barcellini
Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
2021 D. Cattaneo, C. Bucelli, F. Cavallaro, D. Consonni, A. Iurlo
Infectious complications in autoimmune hemolytic anemia
2021 J.A. Giannotta, B. Fattizzo, F. Cavallaro, W. Barcellini
Recent insights into the role of the microbiome in malignant and benign hematologic diseases
2021 B. Fattizzo, F. Cavallaro, F. Folino, W. Barcellini
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020 B. Fattizzo, J.A. Giannotta, W. Barcellini, M.C. Barbanti, C. Bucelli, R. Cassin, D. Cattaneo, F. Cavallaro, V. Ferla, N.S. Fracchiolla, A. Freyrie, G. Galassi, M.C. Goldaniga, F.I. Grifoni, A. Iurlo, G. Mangiameli, V. Mattiello, M. Meli, A. Neri, A. Noto, F. Onida, L. Ottani, R. Pasquale, L. Pettine, A. Pompa, G. Reda, F.G. Rossi, G.N. Saporiti, M. Sciumè, E. Tagliaferri, L. Baldini
Low-dose rituximab in autoimmune hemolytic anemia : 10 years after
2019 B. Fattizzo, A. Zaninoni, L. Pettine, F. Cavallaro, E. Di Bona, W. Barcellini
Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag
2019 B. Fattizzo, F. Cavallaro, G. Milesi, W. Barcellini
Utility of dynamic contrast-enhanced MRI to assess small bowel perfusion in paroxysmal nocturnal hemoglobinuria before and after eculizumab
2018 W. Barcellini, G. Pezzetti, B. Fattizzo, F. Cavallaro, F. De Cobelli
Butyric acid: pharmacological aspects and routes of administration
2007 L. Spina, F. Cavallaro, N.I. Fardowza, P. Lagoussis, D. Bona, C. Ciscato, A. Rigante, M. Vecchi